Deutsche Bank downgraded Givaudan (GVDNY) to Hold from Buy with a price target of CHF 3,000, down from CHF 3,750. The firm adjusted ratings in the European chemicals and ingredients group. While the situation in the Middle East “could change rapidly, for the better or the worse, we view a swift normalization as improbable,” the analyst tells investors in a research note. Deutsche expects the conflict will have relatively long-lasting consequences for European chemical companies, both negative and positive.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GVDNY:
- Givaudan price target lowered to CHF 2,875 from CHF 3,000 at Morgan Stanley
- Givaudan price target lowered to CHF 3,150 from CHF 3,350 at Citi
- Givaudan downgraded to Sell from Buy at Goldman Sachs
- Givaudan price target lowered to CHF 3,350 from CHF 3,500 at Citi
- Givaudan price target lowered to CHF 3,000 from CHF 3,200 at Morgan Stanley